Pernaute-Lau, L., Camara, M., Nóbrega de Sousa, T., Morris, U., Ferreira, M. U., & Gil, J. P. (2022). An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria. Expert Opinion on Drug Metabolism & Toxicology, 18(1), 39–59. https://doi.org/10.1080/17425255.2022.2049235
Maiga, F.O., Wele, M., Toure, S.M. et al. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis.
Malar J 20, 356 (2021). https://doi.org/10.1186/s12936-021-03890-0
Camara, M.D., Zhou, Y., De Sousa, T.N. et al. Meta-analysis of the global distribution of clinically relevant CYP2C8 alleles and their inferred functional consequences. Hum Genomics 18, 40 (2024). https://doi.org/10.1186/s40246-024-00610-y
Camara MD, Zhou Y, Dara A, Tékété MM, Nóbrega de Sousa T, Sissoko S, Dembélé L, Ouologuem N, Hamidou Togo A, Alhousseini ML, Fofana B, Sagara I, Djimde AA, Gil PJ, Lauschke VM. 2024. Population-specific variations in KCNH2 predispose patients to delayed ventricular repolarization upon dihydroartemisinin-piperaquine therapy. Antimicrob Agents Chemother 68:e01390-23.
https://doi.org/10.1128/aac.01390-23
Roukayatou Omorou, Blanche Delabie, Adeline Lavoignat, Victorien Chaker, Guillaume Bonnot, Karim Traore, Anne-Lise Bienvenu, Stephane Picot. Nanoparticle tracking analysis of natural hemozoin from Plasmodium parasites,Acta Tropica, Volume 250, 2024,107105,ISSN 0001-706X, https://doi.org/10.1016/j. Actatropica.2023.107105
Bin Said, I., Kouakou, Y.I., Omorou, R. et al. Systematic review of Plasmodium knowlesi in Indonesia: a risk of emergence in the context of capital relocation to Borneo?. Parasites Vectors 15, 258 (2022). https://doi.org/10.1186/s13071-022-05375-8
Omorou, R., Bin Sa’id, I., Delves, M. et al. Protocols for Plasmodium gametocyte production in vitro: an integrative review and analysis. Parasites Vectors 15, 451 (2022).
https://doi.org/10.1186/s13071-022-05566-3
Kouakou, Y.I., Millet, A., Fromentin, E. et al. Pre-referral intranasal artesunate powder for cerebral malaria: a proof-of-concept study. Malar J 21, 291 (2022).
https://doi.org/10.1186/s12936-022-04309-0
Masters-WANECAM2
Hepatic and renal tolerances of the combinations artemisinin-based therapeutics in the treatment of uncomplicated malaria in Bougoula-Hameau, Sikasso in Mali
Mr Kassim SANOGO, Master of Clinical Biology (defended on May 2022)
Evaluation de la prévalence du paludisme due aux différentes espèces plasmodiales rencontrées dans une zone hyper-endémique à Kati Faladje, Mali.
Mr Siaka GOITA, Master of Parasitology and Medical entomology
(Defended on January 2023).
Evaluation of epidemiological parameters of malaria transmission on a WANECAM 2 site, Kolle, Mali.
Dr Bouran Sidibé, Master of Parasitology and Medical Entomology
(Defended on June 2023)
Evaluation des paramètres paludométriques dans l’aire de santé de Bougoula-Hameau à Sikasso au Mali.
Mr Mohamed Lamine Alhousseini, Master of Parasitology and medical entomology (Defended on September 2023).
Scientifics communications-WANECAM2
Study of biological reference values in the research sites at the Abdou Moumouni University, Niger. EDCTP Forum 7-10 November 2023 Paris, France
In vivo study to monitor the sensitivity of Plasmodium falciparumand other species to
Pyronaridine-artesunate and Artemether-lumefantrine in Niger. Fofana B., BRAH S., Daou M., Togo AH., Bamadio A., Sagara I., Dicko A., Ouedraogo J.B., Adehossi E, Djimde A. (ASTMH 2023).
Clinical trial capacity building from scratch: the WANECAM 2 experience in Niamey, Niger
Abdoulaye Djimde, WANECAM 2 – University of Science, Techniques and Technologies of Bamako (Mali) 7-9 November 2023